Overview

A Study of Rovalpituzumab Tesirine to Study Cardiac Ventricular Repolarization in Subjects With Small Cell Lung Cancer

Status:
Completed

Trial end date:
2018-09-12

Target enrollment:

Participant gender:

Summary

Study to evaluate the effect of rovalpituzumab tesirine on cardiac ventricular repolarization in subjects with small cell lung cancer (SCLC).

Phase:

Phase 1

Details

Lead Sponsor:

Stemcentrx